BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Enrollment complete in pivotal phase III trial of delayed-release cysteamine
Jan. 25, 2011
New melanin-concentrating hormone MCH1 receptor antagonists claimed
Jan. 25, 2011
StronBone Sr-substituted bioactive glass implants show promise in bone grafting
Jan. 25, 2011
Febuxostat approved in Japan for gout
Jan. 24, 2011
Sonias tablet approved in Japan for type 2 diabetes
Jan. 24, 2011
New osteoporosis drug Edirol approved in Japan
Jan. 21, 2011
Chinese scientists develop polycaprolactone-magnesium scaffold for bone repair
Jan. 21, 2011
BioMarin begins phase I/II trial of BMN-701 in late-onset Pompe's disease
Jan. 21, 2011
FDA issues complete response letter to MannKind regarding Afrezza NDA
Jan. 20, 2011
DA-1229 may be beneficial in diabetes types 1 and 2
Jan. 20, 2011
Previous
1
2
…
640
641
642
643
644
645
646
647
648
…
1792
1793
Next
RSS